Table 1 Clinical and pathological data of patient-derived xenografts.
Xenografts | 2 | 17 | 21 | 22 | 36 T, 36 M1, and 36 M3 |
|---|---|---|---|---|---|
TNM | pT2N0M0 | pT3N1M0 | pT2N1M0 | pT2N2M1 | pT3N2M1 |
Stage | I | III | III | IV | IV |
Tumor localization | Right colon | Right colon | Left colon | Right colon | Left colon |
Metastasis localization | NA | NA | NA | Liver and lung | Synchronous liver metastases |
Sex | M | M | F | M | M |
Age (years) | 72 | 77 | 57 | 63 | 74 |
Treatment after surgery | 0 | 0 | FUFOL | FOLFIRI | FOLFOX |
Evolution | No recurrence. Death from hepatocellular carcinoma. | No recurrence. Death from cholangiocarcinoma. | Lung metastasis and lateroaortic adenopathy 2 years after surgery. Still alive 6 years after surgery | Disease progression after 10 months. Death related to cancer 2 years after surgery. | Disease progression after 4 months. Death related to cancer 2 years after surgery. |